Skip to main content

Advertisement

Table 3 Quality indicator performance rates stratified by gender and socioeconomic position, 2015

From: The quality of primary care provided to the elderly in Israel

Influenza vaccination
   Male Female Total
 SEP Age Numerator Denominator Rate Numerator Denominator Rate Numerator Denominator Rate
 Low SEP 65–74 45,214 70,197 64.41% 54,684 94,383 57.94% 99,898 164,580 60.70%
75–84 35,469 50,525 70.20% 47,185 75,635 62.39% 82,654 126,160 65.52%
85 or above 12,234 16,742 73.07% 21,008 32,913 63.83% 33,242 49,655 66.95%
total 92,917 137,464 67.59% 122,877 202,931 60.55% 215,794 340,395 63.40%
 Middle & high SEP 65–74 93,556 156,522 59.77% 97,471 167,895 58.05% 191,027 324,417 58.88%
75–84 50,355 69,352 72.61% 59,586 87,697 67.95% 109,941 157,049 70.00%
85 or above 16,090 22,154 72.63% 23,503 35,656 65.92% 39,593 57,810 68.49%
total 160,001 248,028 64.51% 180,560 291,248 62.00% 340,561 539,276 63.15%
 Total 252,918 385,492 65.61% 303,437 494,179 61.40% 556,355 879,671 63.25%
Pneumococcal vaccination
   Male Female Total
 SEP Age Numerator Denominator Rate Numerator Denominator Rate Numerator Denominator Rate
 Low SEP 65–74 49,631 59,066 84.03% 60,870 77,072 78.98% 110,501 136,138 81.17%
75–84 NA NA NA NA NA NA NA NA NA
85 or above NA NA NA NA NA NA NA NA NA
total 49,631 59,066 84.03% 60,870 77,072 78.98% 110,501 136,138 81.17%
 Middle & high SEP 65–74 164,901 208,638 79.04% 181,131 240,636 75.27% 346,032 449,274 77.02%
75–84 NA NA NA NA NA NA NA NA NA
85 or above NA NA NA NA NA NA NA NA NA
total 164,901 208,638 79.04% 181,131 240,636 75.27% 346,032 449,274 77.02%
 Total 214,532 267,704 80.14% 242,001 317,708 76.17% 456,533 585,412 77.98%
Benzodiazepine overuse
   Male Female Total
 SEP Age Numerator Denominator Rate Numerator Denominator Rate Numerator Denominator Rate
 Low SEP 65–74 2698 70,197 3.84% 4350 94,383 4.61% 7048 164,580 4.28%
75–84 3435 50,525 6.80% 6775 75,635 8.96% 10,210 126,160 8.09%
85 or above 2021 16,742 12.07% 4562 32,913 13.86% 6583 49,655 13.26%
total 8154 137,464 5.93% 15,687 202,931 7.73% 23,841 340,395 7.00%
 Middle & high SEP 65–74 2639 156,522 1.69% 4880 167,895 2.91% 7519 324,417 2.32%
75–84 2888 69,352 4.16% 5848 87,697 6.67% 8736 157,049 5.56%
85 or above 1721 22,154 7.77% 4041 35,656 11.33% 5762 57,810 9.97%
total 7248 248,028 2.92% 14,769 291,248 5.07% 22,017 539,276 4.08%
 Total 15,402 385,492 4.00% 30,456 494,179 6.16% 45,858 879,671 5.21%
Long-term benzodiazepine
   Male Female Total
 SEP Age Numerator Denominator Rate Numerator Denominator Rate Numerator Denominator Rate
 Low SEP 65–74 1675 70,197 2.39% 2567 94,383 2.72% 4242 164,580 2.58%
75–84 1180 50,525 2.34% 2297 75,635 3.04% 3477 126,160 2.76%
85 or above 424 16,742 2.53% 896 32,913 2.72% 1320 49,655 2.66%
total 3279 137,464 2.39% 5760 202,931 2.84% 9039 340,395 2.66%
 Middle & high SEP 65–74 2544 156,522 1.63% 4163 167,895 2.48% 6707 324,417 2.07%
75–84 1478 69,352 2.13% 2713 87,697 3.09% 4191 157,049 2.67%
85 or above 500 22,154 2.26% 1032 35,656 2.89% 1532 57,810 2.65%
total 4522 248,028 1.82% 7908 291,248 2.72% 12,430 539,276 2.30%
 Total 7801 385,492 2.02% 13,668 494,179 2.77% 21,469 879,671 2.44%
BMI documentation
   Male Female Total
 SEP Age Numerator Denominator Rate Numerator Denominator Rate Numerator Denominator Rate
 Low SEP 65–74 53,898 64,758 83.23% 70,201 85,632 81.98% 124,099 150,390 82.52%
75–84 40,220 46,809 85.92% 57,509 69,604 82.62% 97,729 116,413 83.95%
85 or above NA NA NA NA NA NA NA NA NA
total 94,118 111,567 84.36% 127,710 155,236 82.27% 221,828 266,803 83.14%
 Middle & high SEP 65–74 125,290 160,318 78.15% 137,598 174,765 78.73% 262,888 335,083 78.45%
75–84 61,741 74,009 83.42% 77,274 94,670 81.62% 139,015 168,679 82.41%
85 or above NA NA NA NA NA NA NA NA NA
total 187,031 234,327 79.82% 214,872 269,435 79.75% 401,903 503,762 79.78%
 Total 281,149 345,894 81.28% 342,582 424,671 80.67% 623,731 770,565 80.94%
Underweight
   Male Female Total
 SEP Age Numerator Denominator Rate Numerator Denominator Rate Numerator Denominator Rate
 Low SEP 65–74 6122 53,898 11.36% 6816 70,201 9.71% 12,938 124,099 10.43%
75–84 5127 40,220 12.75% 6426 57,509 11.17% 11,553 97,729 11.82%
85 or above 2511 13,178 19.05% 4453 22,450 19.84% 6964 35,628 19.55%
total 13,760 107,296 12.82% 17,695 150,160 11.78% 31,455 257,456 12.22%
 Middle & high SEP 65–74 11,220 125,261 8.96% 19,388 137,576 14.09% 30,608 262,837 11.65%
75–84 7874 62,120 12.68% 11,326 77,765 14.56% 19,200 139,885 13.73%
85 or above 3683 17,688 20.82% 5686 25,961 21.90% 9369 43,649 21.46%
total 22,777 205,069 11.11% 36,400 241,302 15.08% 59,177 446,371 13.26%
 Total 36,537 312,365 11.70% 54,095 391,462 13.82% 90,632 703,827 12.88%
Weight loss
   Male Female Total
 SEP Age Numerator Denominator Rate Numerator Denominator Rate Numerator Denominator Rate
 Low SEP 65–74 2694 44,749 6.02% 3637 57,831 6.29% 6331 102,580 6.17%
75–84 2417 36,760 6.58% 4038 52,070 7.75% 6455 88,830 7.27%
85 or above 923 11,934 7.73% 1904 19,601 9.71% 2827 31,535 8.96%
total 6034 93,443 6.46% 9579 129,502 7.40% 15,613 222,945 7.00%
 Middle & high SEP 65–74 4128 103,165 4.00% 5706 114,904 4.97% 9834 218,069 4.51%
75–84 3398 58,820 5.78% 5062 73,364 6.90% 8460 132,184 6.40%
85 or above 1408 16,582 8.49% 2358 23,628 9.98% 3766 40,210 9.37%
total 8934 178,567 5.00% 13,126 211,896 6.19% 22,060 390,463 5.65%
Total 14,968 272,010 5.50% 22,705 341,398 6.65% 37,673 613,408 6.14%